Multistate DME and pharmacy platform opportunity. $48M+ in revenue. $19M EBITDA. Comprehensive, audited financial statements. Seasoned executive leadership team dedicated to remaining post-transaction.
Multistate DME and pharmacy platform opportunity. $48M+ in revenue. $19M EBITDA. Comprehensive, audited financial statements. Seasoned executive leadership team dedicated to remaining post-transaction.